本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

傳奇生物

37.50
-0.2100-0.56%
盤後37.25-0.2500-0.67%19:56 EDT
成交量:86.90萬
成交額:3,265.05萬
市值:69.21億
市盈率:-21.06
高:38.35
開:37.78
低:37.04
收:37.71
52周最高:59.62
52周最低:27.34
股本:1.85億
流通股本:8,122.39萬
量比:0.67
換手率:1.07%
股息:- -
股息率:- -
每股收益(TTM):-1.7807
每股收益(LYR):-0.9681
淨資產收益率:-29.65%
總資產收益率:-7.81%
市淨率:6.68
市盈率(LYR):-38.73

資料載入中...

2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

SEC問詢函

Form CORRESP - Correspondence
2024/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities